Cargando…
A novel oral prodrug-targeting transporter MCT 1: 5-fluorouracil-dicarboxylate monoester conjugates
Monocarboxylate transporter 1 (MCT1) is responsible for oral absorption of short-chain monocarboxylic acids from small intestine, hence, it's likely to serve as an ideal design target for the development of oral prodrugs. However, potential application of MCT1 to facilitate the oral delivery is...
Autores principales: | Sun, Yixin, Zhao, Dongyang, Wang, Gang, Jiang, Qikun, Guo, Mengran, Kan, Qiming, He, Zhonggui, Sun, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032090/ https://www.ncbi.nlm.nih.gov/pubmed/32104489 http://dx.doi.org/10.1016/j.ajps.2019.04.001 |
Ejemplares similares
-
Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability
por: Wang, Gang, et al.
Publicado: (2020) -
Dicarboxylic Acid Monoesters in β- and δ-Lactam Synthesis
por: Ananeva, Anna, et al.
Publicado: (2022) -
The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine—Feasibility of Orally Administrable Nucleoside Analogs
por: Tsume, Yasuhiro, et al.
Publicado: (2014) -
Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
por: Yang, Jincheng, et al.
Publicado: (2018) -
Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine
por: Tsume, Yasuhiro, et al.
Publicado: (2017)